102 related articles for article (PubMed ID: 4624098)
1. Use of Bacillus Calmette-Guérin as adjuvant in human cell vaccines.
Sokal JE; Aungst CW; Han T
Cancer Res; 1972 Jul; 32(7):1584-9. PubMed ID: 4624098
[No Abstract] [Full Text] [Related]
2. Immunotherapy of chronic myelocytic leukemia.
Sokal JE; Aungst CW; Grace JT
Natl Cancer Inst Monogr; 1973 Dec; 39():195-8. PubMed ID: 4595316
[No Abstract] [Full Text] [Related]
3. Immunologic studies in lymphoma and leukemia, and exploration of antitumor immunotherapy.
Sokal JE
J Surg Oncol; 1973 Jun; 5(6):557-66. PubMed ID: 4589652
[No Abstract] [Full Text] [Related]
4. Immunotherapy with cultured human cells and BCG.
Sokal JE; Aungst CW
Transplant Proc; 1975 Jun; 7(2):317-21. PubMed ID: 1093299
[No Abstract] [Full Text] [Related]
5. Tubercular prostatic abscess as a complication of intravesical bacillus Calmette-Guérin immunotherapy.
Aust TR; Massey JA
Int J Urol; 2005 Oct; 12(10):920-1. PubMed ID: 16323989
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for chronic myelogenous leukemia: survival not affected by treatment in the stable phase.
Baker MA; Taub RN; Carter WH; Davidson M; Sutton DM; Kutas G; Berger S; Watt HJ
Cancer Res; 1984 Jan; 44(1):383-5. PubMed ID: 6360347
[TBL] [Abstract][Full Text] [Related]
7. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. II. Reticulosarcoma. (Correlation with the immunity reaction of the cellular type and the clinical status).
Libánský J; Sedlácková M; Pinosová I
Neoplasma; 1973; 20(1):61-7. PubMed ID: 4573872
[No Abstract] [Full Text] [Related]
8. Bacillus Calmette-Guerin mechanism of action: the role of immunity, apoptosis, necrosis and autophagy.
DiPaola RS; Lattime EC
J Urol; 2007 Nov; 178(5):1840-1. PubMed ID: 17868741
[No Abstract] [Full Text] [Related]
9. Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and bacillus Calmette-Guèrin: five-year results of a prospective randomized study.
Galligioni E; Quaia M; Merlo A; Carbone A; Spada A; Favaro D; Santarosa M; Sacco C; Talamini R
Cancer; 1996 Jun; 77(12):2560-6. PubMed ID: 8640706
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy in well-controlled chronic myelocytic leukemia.
Sokal JE; Aungst CW; Grace JT
N Y State J Med; 1973 May; 73(10):1180-5. PubMed ID: 4512241
[No Abstract] [Full Text] [Related]
11. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer vaccines: current status.
Hwang LC; Fein S; Levitsky H; Nelson WG
Semin Oncol; 1999 Apr; 26(2):192-201. PubMed ID: 10597730
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.
Yossepowitch O; Eggener SE; Bochner BH; Donat SM; Herr HW; Dalbagni G
J Urol; 2006 Aug; 176(2):482-5. PubMed ID: 16813873
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccination using bacillus Calmette-Guerin-DNA as an adjuvant to enhance immune response to three kinds of swine diseases.
Zhang S; Guo YJ; Sun SH; Wang KY; Wang KH; Zhang Y; Zhu WJ; Chen ZH; Jiang L
Scand J Immunol; 2005 Oct; 62(4):371-7. PubMed ID: 16253124
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants.
Hernández A; Yager JA; Wilkie BN; Leslie KE; Mallard BA
Vet Immunol Immunopathol; 2005 Mar; 104(1-2):45-58. PubMed ID: 15661330
[TBL] [Abstract][Full Text] [Related]
16. Bacillus Calmette-Guerin, Mycobacterium bovis, as an immunomodulator in atopic diseases.
Barlan I; Bahceciler NN; Akdis M; Akdis CA
Immunol Allergy Clin North Am; 2006 May; 26(2):365-77, ix. PubMed ID: 16701150
[TBL] [Abstract][Full Text] [Related]
17. Immunity in leukemias.
Ranjan R; Singh VP; Singh NK; Srivastava PK; Gupta RM; Gupta YN
J Assoc Physicians India; 1984 Jun; 32(6):469-71. PubMed ID: 6511718
[No Abstract] [Full Text] [Related]
18. Total cell-associated immunoglobulin (TCAI) and immunoglobulin (Ig)synthesis of human leukocytes.
Longmire R; McMillan R; Yelenosky R; Craddock C
Trans Assoc Am Physicians; 1971; 84():229-38. PubMed ID: 5172851
[No Abstract] [Full Text] [Related]
19. [Immunoglobulins deficiency as a fatal prognostic sign in leukemia and lymphoreticular diseases].
Rodríguez Cuartero A; Núñez Carril J
Rev Clin Esp; 1974 Apr; 133(2):149-54. PubMed ID: 4210816
[No Abstract] [Full Text] [Related]
20. [Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes].
Iturralde Codina A; Beyríe Tamayo W; Gozá León F; Muñoz YI
Arch Esp Urol; 2004; 57(6):606-18. PubMed ID: 15382436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
